New Risk Factors Identified for Parasitic Infection
By LabMedica International staff writers Posted on 24 Jul 2013 |

Image: Egg of Paragonimus westermani (Photo courtesy of US Center of Disease Control and Prevention).
Recent cases of a parasitic lung infection have been analyzed and new modes of transmission and associated behaviors have identified among different groups of people at risk.
The index of suspicion among medical professionals should be raised so nontraditional patients and those not exhibiting all symptoms, but who are at risk can be diagnosed and treated to avoid potentially life-threatening lung or brain complications.
A public health professional at the Louisiana State University Health Sciences Center (New Orleans, LA, USA) has reviewed the status of paragonimiasis in the USA, as the epidemiology of this disease has recently changed. The disease is caused by trematode worms, such as Paragonimus westermani, and P. kellicotti. Most cases of infection are reported from Asia or in those who have recently traveled to or emigrated from a region where the parasite is prevalent.
In the laboratory, the diagnosis of paragonimiasis may include the microscopic observation of unembryonated Paragonimus eggs in sputum, feces, bronchoalveolar lavage (BAL) fluid, lung or pleural biopsy specimens, or surgical pleurectomy or lobectomy specimens. A variety of more sensitive immunodiagnostic techniques are available from reference laboratories, including enzyme-linked immunosorbent assays (ELISAs) and immunoblotting developed for the detection of cross-reacting P. westermani antibodies. Some of the newest diagnostic technologies for the rapid detection of food-borne helminthiases, including paragonimiasis, are loop-mediated isothermal amplification (LAMP) assays, DNA pyrosequencing for polymerase chain reaction (PCR) amplicons, and multiplex protein microarray assays.
The parasitic infection can occur when crabs are eaten raw in sushi bars or alcohol-pickled crabs, the so-called drunken crabs, in martinis. The one indigenous Paragonimus species can transmit infection through undercooked mudbugs at a crawfish boil and through exposure while floating, paddling, canoeing, or camping on waterways and in areas where crawfish live. The incubation period can vary from two to six weeks. Although some people can remain asymptomatic for prolonged periods, this parasitic infection can produce symptoms ranging from fever, recurrent cough, and night sweats, mimicking tuberculosis, to bloody cough, pleurisy, and pneumonia. It can cause headaches, seizures, stiff neck, and loss of vision and can be fatal.
James H. Diaz, MD, DrPH, the author of the article, said, “Doctors should consider this infection in vacationers and weekenders returning from areas of the USA where the parasite is endemic and ask about raw or undercooked crawfish in all patients with unexplained fever, cough, high white blood cell count, and fluid around the lungs. Even without microscopic evidence, any patient with a positive history of raw or undercooked freshwater Asian crab or native crawfish and clinical symptoms should be evaluated and treated to prevent serious complications.” The review was published in the July 2013 issue of the journal Clinical Microbiology Reviews.
Related Links:
Louisiana State University Health Sciences Center
The index of suspicion among medical professionals should be raised so nontraditional patients and those not exhibiting all symptoms, but who are at risk can be diagnosed and treated to avoid potentially life-threatening lung or brain complications.
A public health professional at the Louisiana State University Health Sciences Center (New Orleans, LA, USA) has reviewed the status of paragonimiasis in the USA, as the epidemiology of this disease has recently changed. The disease is caused by trematode worms, such as Paragonimus westermani, and P. kellicotti. Most cases of infection are reported from Asia or in those who have recently traveled to or emigrated from a region where the parasite is prevalent.
In the laboratory, the diagnosis of paragonimiasis may include the microscopic observation of unembryonated Paragonimus eggs in sputum, feces, bronchoalveolar lavage (BAL) fluid, lung or pleural biopsy specimens, or surgical pleurectomy or lobectomy specimens. A variety of more sensitive immunodiagnostic techniques are available from reference laboratories, including enzyme-linked immunosorbent assays (ELISAs) and immunoblotting developed for the detection of cross-reacting P. westermani antibodies. Some of the newest diagnostic technologies for the rapid detection of food-borne helminthiases, including paragonimiasis, are loop-mediated isothermal amplification (LAMP) assays, DNA pyrosequencing for polymerase chain reaction (PCR) amplicons, and multiplex protein microarray assays.
The parasitic infection can occur when crabs are eaten raw in sushi bars or alcohol-pickled crabs, the so-called drunken crabs, in martinis. The one indigenous Paragonimus species can transmit infection through undercooked mudbugs at a crawfish boil and through exposure while floating, paddling, canoeing, or camping on waterways and in areas where crawfish live. The incubation period can vary from two to six weeks. Although some people can remain asymptomatic for prolonged periods, this parasitic infection can produce symptoms ranging from fever, recurrent cough, and night sweats, mimicking tuberculosis, to bloody cough, pleurisy, and pneumonia. It can cause headaches, seizures, stiff neck, and loss of vision and can be fatal.
James H. Diaz, MD, DrPH, the author of the article, said, “Doctors should consider this infection in vacationers and weekenders returning from areas of the USA where the parasite is endemic and ask about raw or undercooked crawfish in all patients with unexplained fever, cough, high white blood cell count, and fluid around the lungs. Even without microscopic evidence, any patient with a positive history of raw or undercooked freshwater Asian crab or native crawfish and clinical symptoms should be evaluated and treated to prevent serious complications.” The review was published in the July 2013 issue of the journal Clinical Microbiology Reviews.
Related Links:
Louisiana State University Health Sciences Center
Latest Microbiology News
- New Blood Test Detects Up to Five Infectious Diseases at POC
- Molecular Stool Test Shows Potential for Diagnosing TB in Adults with HIV
- New Test Diagnoses Bacterial Meningitis Quickly and Accurately
- Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
- New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
- Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
- Innovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR
- Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
- Rapid PCR Testing in ICU Improves Antibiotic Stewardship
- Unique Genetic Signature Predicts Drug Resistance in Bacteria
- Unique Barcoding System Tracks Pneumonia-Causing Bacteria as They Infect Blood Stream
- Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application
- Rapid Diagnostic System to Detect Neonatal Sepsis Within Hours
- Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood
- Interferon-γ Release Assay Effective in Patients with COPD Complicated with Pulmonary Tuberculosis
- New Point of Care Tests to Help Reduce Overuse of Antibiotics
Channels
Clinical Chemistry
view channel
AI-Powered Blood Test Accurately Detects Ovarian Cancer
Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more
Automated Decentralized cfDNA NGS Assay Identifies Alterations in Advanced Solid Tumors
Current circulating cell-free DNA (cfDNA) assays are typically centralized, requiring specialized handling and transportation of samples. Introducing a flexible, decentralized sequencing system at the... Read moreMass Spectrometry Detects Bacteria Without Time-Consuming Isolation and Multiplication
Speed and accuracy are essential when diagnosing diseases. Traditionally, diagnosing bacterial infections involves the labor-intensive process of isolating pathogens and cultivating bacterial cultures,... Read more
First Comprehensive Syphilis Test to Definitively Diagnose Active Infection In 10 Minutes
In the United States, syphilis cases have surged by nearly 80% from 2018 to 2023, with 209,253 cases recorded in the most recent year of data. Syphilis, which can be transmitted sexually or from mother... Read moreMolecular Diagnostics
view channel
POC Oral Swab Test to Increase Chances of Pregnancy in IVF
Approximately 15% of couples of reproductive age experience involuntary childlessness. A significant reason for this is the growing trend of delaying family planning, a global shift that is expected to... Read more
Microbial Cell-Free DNA Test Accurately Identifies Pathogens Causing Pneumonia and Other Lung Infections
Bronchoalveolar lavage (BAL) is a commonly used procedure for diagnosing lung infections, especially in immunocompromised patients. However, standard tests often fail to pinpoint the exact pathogen, leading... Read moreHematology
view channel
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read more
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read morePathology
view channel
Groundbreaking Chest Pain Triage Algorithm to Transform Cardiac Care
Cardiovascular disease is responsible for a third of all deaths worldwide, and chest pain is the second most common reason for emergency department (ED) visits. With EDs often being some of the busiest... Read more
AI-Based Liquid Biopsy Approach to Revolutionize Brain Cancer Detection
Detecting brain cancers remains extremely challenging, with many patients only receiving a diagnosis at later stages after symptoms like headaches, seizures, or cognitive issues appear. Late-stage diagnoses... Read moreTechnology
view channel
Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer
Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses
Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read moreIndustry
view channel
Qiagen Acquires NGS Analysis Software Company Genoox
QIAGEN (Venlo, the Netherlands) has signed a definitive agreement to acquire Genoox (Tel Aviv, Israel), a provider of artificial intelligence (AI)-powered software that enables clinical labs to scale and... Read more
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more